AMRI Launches its U.S. Integrated Drug Discovery Center

Go back to AMRI Launches its U.S. Integrated Drug Discovery Center

AMRI (AMRI) Debuts New U.S.-Based Integrated Drug Discovery Center

December 7, 2015 8:17 AM UTC

Albany Molecular Research Inc. (NASDAQ: AMRI) introduces its new U.S.-based integrated drug discovery center in Buffalo, N.Y. Located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, this drug discovery center offers customers leading-edge platforms and capabilities for developing new approaches to discover life-saving therapies. The center will increase translation to the clinic by leveraging expertise in biology, high-throughput screening (HTS), medicinal chemistry and pharmacology integrated within a single site in the United States.

"We are... More